HNB
AVXL icon

Huntington National Bank’s Anavex Life Sciences AVXL Stock Holding History

Huntington National Bank’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-700
Closed -$4.58K – 3868
2023
Q3 		$4.58K Hold
700
– – ﹤0.01% 1844
2023
Q2 		$5.69K Buy
+700
New +$6K ﹤0.01% 1757

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Huntington National Bank's AVXL Position: Q4 2023 in Review

Huntington National Bank sold out of Anavex Life Sciences (AVXL) in Q4 2023, closing a stake of 700 shares — an estimated $4.58K sold.

Huntington National Bank first reported a position in AVXL in Q2 2023 and held it in 2 quarters. The position peaked at $5.69K in Q2 2023. 153 funds tracked by Wall St. Rank hold AVXL as of Q4 2023.

  • Huntington National Bank reported no remaining Anavex Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Huntington National Bank sold 700 Anavex Life Sciences shares in Q4 2023, an estimated $4.58K.
  • Huntington National Bank first reported a position in Anavex Life Sciences in Q2 2023 and held it in 2 quarters.
  • Huntington National Bank's Anavex Life Sciences position peaked at $5.69K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2023.

Based on Huntington National Bank's 13F filing for Q4 2023, filed 7 Feb 2024.